Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
China National Intellectual Property Administration has granted a patent covering potency assay methods for assessing human mesenchymal stem cells (MSCs).
-
Longeveron reported financial results for the year ended December 31, 2025 and provided a business update. Results from pivotal P2 trial anticipated 3Q26.
-
Longeveron to report 2025 full year financial results and provide a business update on March 17, 2026 after the U.S. financial markets close.
-
Longeveron announces closing of previously announced up to $30 million private placement.
-
Longeveron announces private placement financing of up to $30 million.